HQY - HealthEquity, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $115.33 DETAILS

Stock News

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.

Sep 04, 2026 07:53 AM • zacks.com

HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?

HealthEquity's 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.

Sep 02, 2026 10:46 AM • zacks.com

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sep 02, 2026 06:45 AM • zacks.com

Why HealthEquity Stock Sank This Week

HealthEquity posted significant sales and earnings beats with its fiscal Q2 report. The company issued a small increase for its full-year guidance, but management kept its forecast for adjusted earnings per share the same.

Aug 30, 2026 03:15 AM • fool.com

Canada Pension Plan Investment Board Makes New Investment in HealthEquity, Inc. $HQY

Canada Pension Plan Investment Board purchased a new stake in HealthEquity, Inc. (NASDAQ: HQY) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 135,600 shares of the company's stock, valued at approximately $12,247,000. Canada Pension Plan Investment Board owned 0.16% of

Aug 30, 2026 12:26 AM • defenseworld.net

HealthEquity Q2 Earnings Call Highlights

HealthEquity (NASDAQ: HQY) reported accelerated revenue growth and record profitability in its fiscal 2027 second quarter, citing HSA account expansion, higher member engagement and technology-driven service efficiencies. The company raised its full-year outlook after generating record adjusted EBITDA margin of 48%. "Q1 demonstrated that the model is scaling, and Q2 showed that the model is becoming

Aug 28, 2026 09:02 PM • defenseworld.net

HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript

Aug 27, 2026 10:39 AM • seekingalpha.com

HealthEquity Q2 Earnings Call Highlights

HealthEquity NASDAQ: HQY reported accelerated revenue growth and record profitability in its fiscal 2027 second quarter, citing HSA account expansion, higher member engagement and technology-driven service efficiencies. The company raised its full-year outlook after generating record adjusted EBITDA margin of 48%.

Aug 27, 2026 07:06 AM • marketbeat.com

HealthEquity (HQY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Aug 27, 2026 07:01 AM • zacks.com

HealthEquity (HQY) Q2 Earnings and Revenues Top Estimates

HealthEquity (HQY) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.08 per share a year ago.

Aug 27, 2026 06:36 AM • zacks.com

HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results

Highlights of the second quarter include: Net income increased 10% to $65.6 million, and net income margin increased to 19% from 18% last year. Adjusted EBITDA increased 11% to $167.0 million, and Adjusted EBITDA margin increased to 48% from 46% last year.

Aug 27, 2026 04:00 AM • globenewswire.com

Bamco Inc. NY Invests $67.78 Million in HealthEquity, Inc. $HQY

Bamco Inc. NY bought a new position in HealthEquity, Inc. (NASDAQ: HQY) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 750,394 shares of the company's stock, valued at approximately $67,776,000. Bamco Inc. NY owned 0.90% of HealthEquity as of its most recent filing with the

Aug 27, 2026 12:55 AM • defenseworld.net

Ahead of HealthEquity (HQY) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2026.

Aug 24, 2026 06:17 AM • zacks.com

Handelsbanken Fonder AB Has $3.28 Million Stake in HealthEquity, Inc. $HQY

Handelsbanken Fonder AB boosted its position in shares of HealthEquity, Inc. (NASDAQ: HQY) by 20.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,316 shares of the company's stock after purchasing an additional 6,100 shares during the

Aug 15, 2026 11:46 PM • defenseworld.net

HealthEquity, Inc. $HQY Shares Purchased by Amundi

Amundi increased its holdings in HealthEquity, Inc. (NASDAQ: HQY) by 2,130.8% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 67,592 shares of the company's stock after acquiring an additional 64,562 shares during the quarter. Amundi owned approximately 0.08% of HealthEquity worth

Aug 05, 2026 11:05 PM • defenseworld.net

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

DRAPER, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its second quarter of fiscal 2027, before the opening of regular stock market trading on Thursday, August 27, 2026. Following the news release, HealthEquity management will host a conference call for investors on Thursday, August 27, 2026, at 8:30 a.m. Eastern Time to review the Company's second quarter results.

Aug 03, 2026 12:00 PM • globenewswire.com

HealthEquity (HQY) Upgraded to Buy: What Does It Mean for the Stock?

HealthEquity (HQY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Aug 03, 2026 09:01 AM • zacks.com

Castleark Management LLC Purchases New Position in HealthEquity, Inc. $HQY

Castleark Management LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ: HQY) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 48,510 shares of the company's stock, valued at approximately $4,054,000. Castleark Management LLC owned approximately

Jul 28, 2026 12:10 AM • defenseworld.net

HealthEquity's Earnings Momentum Deserves More Credit

HealthEquity is the leading HSA and CDB administrator, consistently beating revenue and EPS expectations with strong operational execution. HQY's fiscal 2027 revenue is guided to $1.41–$1.42 billion, with robust HSA asset growth, margin expansion, and accelerating buybacks supporting a Buy rating. Custodial yield remains resilient at 3.84%, supported by rate locks through 2029, while automation and AI investments drive significant cost efficiencies.

Jul 27, 2026 04:18 AM • seekingalpha.com

Bank of New York Mellon Corp Lowers Position in HealthEquity, Inc. $HQY

Bank of New York Mellon Corp trimmed its position in HealthEquity, Inc. (NASDAQ: HQY) by 3.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 599,254 shares of the company's stock after selling 22,625 shares during the quarter. Bank of New York Mellon

Jul 25, 2026 12:05 AM • defenseworld.net